State Directory
Provider Records in Washington
GLP1Search tracks 386 provider records across 44 Washington cities. 13 records include explicit GLP-1, medication, or peptide treatment evidence; 373 are directory-only healthcare/provider records that need direct confirmation.
Provider Records
386
Cities
44
Treatment Evidence
13
Directory-Only
373
Market Snapshot
Where source-ready GLP-1 records are concentrated in Washington
The Washington source-ready local index is led by Seattle. Across the state, 97% of provider records include phone plus address or website coverage, 10% list public pricing, and 4% carry an upstream source/place signal.
Data Complete
97%
Pricing Visible
10%
Source Flagged
4%
Treatment-Specific Directories
Medication and peptide location pages for Washington
These pages focus on high-intent treatment searches where the state has enough listing density to support a useful directory page.
Top Washington cities for source-ready GLP-1 records
Featured provider records in Washington
Well Medical ArtsSeattle · Contact for PricingSemaglutide evidence, Tirzepatide evidenceSeattle Plastic SurgerySeattle · Contact for PricingSemaglutide evidence, Tirzepatide evidenceModern Medical SpaRichland · Monthly plans; Concierge accessSemaglutide, Tirzepatide, Body ContouringRebel Med NWSeattle · Contact for PricingSemaglutide evidence, Tirzepatide evidenceFlow Wellness | SeattleSeattle · $500+Semaglutide evidence, Tirzepatide evidenceSeattle Weight Loss & WellnessSeattle · $500+Semaglutide evidence, Tirzepatide evidenceSkin Haven Cosmetic ClinicSeattle · $500+Semaglutide evidence
All covered cities in Washington
Questions about provider records in Washington
How many providers are listed?
GLP1Search lists 386 provider records across 44 cities in Washington, including 13 treatment-evidence records and 373 directory-only records to verify.
Which cities have the most listings?
Seattle (202), Bellevue (52), Kirkland (18), Vancouver (8), Lynnwood (7) currently have the highest listing density in Washington.
What should patients compare?
Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.